Cargando…

Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis

We present an in vitro susceptibility assay for Madurella mycetomatis hyphae using resazurin for endpoint reading. Using this assay, reproducible MICs were obtained for amphotericin B, itraconazole, voriconazole, posaconazole, terbinafine, and micafungin. Results were comparable with those of a 2,3-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd Algaffar, S. O., Verbon, A., van de Sande, W. W. J., Khalid, S. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Susceptibility
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092548/ https://www.ncbi.nlm.nih.gov/pubmed/33318015 http://dx.doi.org/10.1128/AAC.01338-20

Ejemplares similares

Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma
por: Abd Algaffar, S O, et al.
Publicado: (2022)

Madurella mycetomatis Is Highly Susceptible to Ravuconazole
por: Ahmed, Sarah Abdalla, et al.
Publicado: (2014)

Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim
por: Lim, Wilson, et al.
Publicado: (2020)

The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo
por: Konings, Mickey, et al.
Publicado: (2023)

Madurella mycetomatis grains within a eumycetoma lesion are clonal
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

A Histopathological Exploration of the Madurella mycetomatis Grain
por: Ibrahim, Anahid Izzat, et al.
Publicado: (2013)

Mycetoma due to Madurella mycetomatis
por: Sigera, L.S.M., et al.
Publicado: (2020)

A Madurella mycetomatis Grain Model in Galleria mellonella Larvae
por: Kloezen, Wendy, et al.
Publicado: (2015)

The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach
por: Lim, Wilson, et al.
Publicado: (2020)

The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent
por: Elfadil, Hassabelrasoul, et al.
Publicado: (2015)

Epidemiological cut‐off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma
por: Nyuykonge, Bertrand, et al.
Publicado: (2022)

Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella
por: Lim, Wilson, et al.
Publicado: (2022)

S6.5b Genomics and metagenomics of Madurella mycetomatis
por: Litvintseva, Anastasia, et al.
Publicado: (2022)

Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae
por: Sheehan, Gerard, et al.
Publicado: (2020)

In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles
por: Wood, Gwendolyn E., et al.
Publicado: (2023)

Active Matrix Metalloprotease-9 Is Associated with the Collagen Capsule Surrounding the Madurella mycetomatis Grain in Mycetoma
por: Geneugelijk, Kirsten, et al.
Publicado: (2014)

In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019)
por: Li, Xuechun, et al.
Publicado: (2022)

In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
por: Sobel, Jack D., et al.
Publicado: (2021)

In Vitro Susceptibility to Closthioamide among Clinical and Reference Strains of Neisseria gonorrhoeae
por: Miari, Victoria F., et al.
Publicado: (2017)

Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge
por: Sampaio, Felipe Maurício Soeiro, et al.
Publicado: (2013)

Two simultaneous mycetomas caused by Fusarium verticillioides and Madurella mycetomatis
por: Bonifaz, Alexandro, et al.
Publicado: (2017)

Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects
por: Elkheir, Lamis Y. M., et al.
Publicado: (2020)

Pulmonary Madurella mycetomatis mycetoma secondary to knee eumycetoma, Senegal
por: Diongue, Khadim, et al.
Publicado: (2021)

Phylogenetic Analysis of the Complete Mitochondrial Genome of Madurella mycetomatis Confirms Its Taxonomic Position within the Order Sordariales
por: van de Sande, Wendy W. J.
Publicado: (2012)

The Combination of Amoxicillin-Clavulanic Acid and Ketoconazole in the Treatment of Madurella mycetomatis Eumycetoma and Staphylococcus aureus Co-infection
por: Mhmoud, Najwa A., et al.
Publicado: (2014)

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
por: Rancoita, Paola M. V., et al.
Publicado: (2018)

Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017)

The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma
por: Konings, Mickey, et al.
Publicado: (2021)

Most-Probable-Number-Based Minimum Duration of Killing Assay for Determining the Spectrum of Rifampicin Susceptibility in Clinical Mycobacterium tuberculosis Isolates
por: Vijay, Srinivasan, et al.
Publicado: (2021)

In Vitro Activity of Gepotidacin against Gram-Negative and Gram-Positive Anaerobes
por: Hackel, Meredith A., et al.
Publicado: (2022)

Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018
por: Le, Wenjing, et al.
Publicado: (2021)

In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis
por: Shetye, Gauri S., et al.
Publicado: (2021)

Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates In Vitro and in a Mouse Model of Pulmonary Infection
por: Nicklas, Danielle A., et al.
Publicado: (2022)

In Vitro Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

In Vitro Activity of Meropenem-Vaborbactam against Clinical Isolates of KPC-Positive Enterobacteriaceae
por: Hackel, Meredith A., et al.
Publicado: (2017)

Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis
por: Gold, Ben, et al.
Publicado: (2015)

Epitope-Based Peptide Vaccine Against Fructose-Bisphosphate Aldolase of Madurella mycetomatis Using Immunoinformatics Approaches
por: Mohammed, Arwa A, et al.
Publicado: (2018)

In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila
por: Dubois, Jacques, et al.
Publicado: (2020)

Genome Sequence of Madurella mycetomatis mm55, Isolated from a Human Mycetoma Case in Sudan
por: Smit, Sandra, et al.
Publicado: (2016)

Gametocytes from K13 Propeller Mutant Plasmodium falciparum Clinical Isolates Demonstrate Reduced Susceptibility to Dihydroartemisinin in the Male Gamete Exflagellation Inhibition Assay
por: Lozano, Sonia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3lrt9709c0n1blq9v1f5i9ic3l